Antibiotic stewardship: governance beyond simply reducing use

Appropriateness is the aim

CDC describes hospital stewardship as promoting appropriate antibiotic use to improve care and address resistance.^[1] Reducing volume without considering clinical need is therefore an inadequate goal. Governance should support necessary treatment while creating a reliable way to review avoidable use.

What a programme requires

CDC outlines leadership commitment, accountability, pharmacy expertise, action, tracking, reporting and education.^[1] AHRQ adds tools connecting programme development, safety culture and antibiotic decisions.^[2] A committee appointment alone does not demonstrate that these activities occur in everyday care.

A bounded starting point

ICORP suggests agreeing one concrete problem first, such as missing indications or inconsistent review after results become available. Choose an activity with an accountable team, allocated time and accessible consultation. If preauthorisation is adopted, design access to advice so that the process does not obstruct necessary treatment.

Use reports for improvement

Suggested reports combine implementation, antibiotic use and clinical-team-selected outcomes or adverse effects. Interpret them with patient acuity and microbiology information, and return findings to prescribers and leadership. Lower consumption alone is not sufficient evidence of success. This is programme-governance guidance, not a prescription for individual patients.